Details for New Drug Application (NDA): 065390
✉ Email this page to a colleague
The generic ingredient in RIFAMPIN is isoniazid; rifampin. There are five drug master file entries for this compound. Additional details are available on the isoniazid; rifampin profile page.
Summary for 065390
Tradename: | RIFAMPIN |
Applicant: | Chartwell Molecular |
Ingredient: | rifampin |
Patents: | 0 |
Suppliers and Packaging for NDA: 065390
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIFAMPIN | rifampin | CAPSULE;ORAL | 065390 | ANDA | Chartwell RX, LLC | 62135-315 | 62135-315-30 | 30 CAPSULE in 1 BOTTLE (62135-315-30) |
RIFAMPIN | rifampin | CAPSULE;ORAL | 065390 | ANDA | Chartwell RX, LLC | 62135-316 | 62135-316-60 | 60 CAPSULE in 1 BOTTLE (62135-316-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 150MG | ||||
Approval Date: | Mar 28, 2008 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
Approval Date: | Mar 28, 2008 | TE: | AB | RLD: | No |
Complete Access Available with Subscription